Microbix Biosystems Inc T.MBX

New Press Release - Microbix Reports Results for Q3 Fiscal 2023

Strong Sales of $5.5 million alongside Drug Partnering Agreement MISSISSAUGA, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and YTD fiscal 2023...read article.

[wizzdumb]

Can't say the inventory write-off is surprising, the DxTm line seems to be dead regardless of their optimism that they can salvage something from it and all their rosy predictions about non COVID applications. They should just put this behind them, government is rarely a good partner.   QAPs sales disappointing but also not surprising due to lack of any new partnership announcements. Q4

[Mbxwatcher]

Id say we are at the precipice here...... We have not proven that QAPs is the business opportunity we have prepared for. VTM is an absolute dissappointment without reservation.  There is a whole world out there, and we have sold zero.  I agree that government is not a good partner, but ultimately our team is responsible for this mess, including the inventory write-off.  Id be happy

[lscfa]

Deferred revenue increased by $1.55 million